"Making blood draws less traumatic for children could go a long way to making their whole hospital experience better. We're looking forward to working with Velano Vascular to see how this technology can help improve care for the kids we treat," said Ann-Christine Duhaime, MD, NEPDC Co-Director and Director of the Pediatric Neurosurgery Department at Massachusetts General Hospital.
After a successful early engagement with Velano Vascular and their product, PIVO™, an FDA cleared device that makes inpatient blood draws a seamless and stress-free experience by reducing the number of sticks for blood collection, NEPDC will continue to support Velano Vascular in their efforts to engineer the device for use in smaller children and infants.
"We are honored to act as collaborators with NEPDC and the FDA in pursuit of a shared vision to eliminate the pain and anxiety that kids so closely associate with this necessary medical procedure," said Velano Vascular CEO Eric M. Stone. "With PIVO, pediatric blood draws can become a less stressful, more pleasant experience for both children and their parents."
NEPDC offers commercialization resources for pediatric medical devices through a seed grant program made possible through funds from the FDA Office of Orphan Product Development.
About New England Pediatric Device Consortium (NEPDC)
NEPDC is a non-profit consortium that provides infrastructure, expert consultation to innovators, and execution of technology translation and commercialization of pediatric technologies. For further information, visit www.NEPDC.org.
About Velano Vascular
Velano Vascular is committed to reducing the pain, risk, and inefficiencies of vascular access and blood collection practices. Velano Vascular's PIVO device enables blood draws from Peripheral IV catheters, aiming to enable more compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. Velano Vascular is backed by First Round Capital, Griffin Hospital, Kapor Capital, Safeguard Scientifics, Sutter Health, The Children's Hospital of Philadelphia (CHOP), White Owl Capital, and a number of health-industry veterans. Company collaborators include several of the leading hospital systems in the United States. More information is available at www.velanovascular.com and @velanovascular.
CONTACT: Cassie Brugger, 603-678-8260, email@example.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/new-england-pediatric-device-consortium-awards-velano-vascular-in-support-of-needle-free-blood-draw-technology-300429055.html
|SOURCE New England Pediatric Device Consortium|
Copyright©2017 PR Newswire.
All rights reserved
Related medicine technology :
1. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
2. Een studie in het New England Journal of Medicine bevestigt dat universele dekolonisatie van ic-patiënten voor 44% minder bloedstroominfecties zorgt
3. Ibrutinib Study Results in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Published in The New England Journal of Medicine
4. Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine
5. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
6. CVS Caremark Uses Data to Combat National Prescription Drug Abuse Epidemic; Program Details Published in New England Journal of Medicine Online
7. New England Laser Options Adds On Professional Hair Removal with the Astanza Liberty IPL System
8. New England Journal of Medicine releases study showing GSKs FluLaval Quadrivalent vaccine effective in preventing seasonal flu in children
9. Romosozumab Phase 2 Data Published In New England Journal Of Medicine Show Significant Increases In Bone Mineral Density At Both Spine And Hip
10. Lyophilization Services of New England Completes FDA Inspection
11. New England Journal of Medicine Study Finds Upper-Airway Electronic Stimulation Effective for Obstructive Sleep Apnea